J. Andersson

Breast cancer screening with mammography: overview of Swedish randomised trials

L. Nyström, Stig Wall, L. E. Rutqvist et al. · The Lancet · 1993 · 978 citations

Medicine, Preventive Medicine, Radiology +12

Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF

J. Andersson, Lena Larsson, Sigrid Klaar et al. · Annals of Oncology · 2005 · 57 citations

Medicine, Oncology, Breast Oncology +15

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

Barbro Linderholm, J. Andersson, Birgitta Lindh et al. · European Journal of Cancer · 2003 · 49 citations

Medicine, Oncology, Breast Oncology +12

HER-2/neu (c-erbB-2) Evaluation in Primary Breast Carcinoma by Fluorescent In Situ Hybridization and Immunohistochemistry With Special Focus on Intratumor Heterogeneity and Comparison of Invasive and In Situ Components

J. Andersson, Barbro Linderholm, Jonas Bergh et al. · Applied immunohistochemistry & molecular morphology · 2004 · 41 citations

Medicine, Oncology, Pathology +16

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden

J. Andersson, Barbro Linderholm, Gudrun Greim et al. · Acta Oncologica · 2002 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15